Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature

Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature

An 83-year-old patient developed erosions and a blister of the gingival mucous membrane, 6 months after discontinuation of the anti-programmed death-1 (anti PD-1) pembrolizumab therapy administered for 10 months for a metastatic melanoma. A diagnosis of mild mucous membrane pemphigoid (MMP) was made...

Full description

Bibliographic Details
Main Authors: Coralie Zumelzu, Marina Alexandre, Christelle Le Roux, Patricia Weber, Alexis Guyot, Annie Levy, Françoise Aucouturier, Sabine Mignot-Grootenboer, Frédéric Caux, Eve Maubec, Catherine Prost-Squarcioni
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Medicine
Subjects:
mucous membrane pemphigoid
bullous pemphigoid
melanoma
anti-programmed-death-1/death-ligand-1
immune checkpoints inhibitors
pembrolizumab
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2018.00268/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2018.00268/full

Similar Items